Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
Kopeć G, Forfia P, Abe K, Beaudet A, Gressin V, Jevnikar M, Meijer C, Tan YZ, Moiseeva O, Sheares K, Skoro-Sajer N, Terra-Filho M, Whitford H, Zhai Z, Heresi GA. Kopeć G, et al. Among authors: skoro sajer n. Pulm Circ. 2024 Feb 21;14(1):e12330. doi: 10.1002/pul2.12330. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38384932 Free PMC article.
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial.
Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM. Sadushi-Kolici R, et al. Lancet Respir Med. 2019 Mar;7(3):239-248. doi: 10.1016/S2213-2600(18)30367-9. Epub 2018 Nov 23. Lancet Respir Med. 2019. PMID: 30477763 Clinical Trial.
Predictors of outcome in chronic thromboembolic pulmonary hypertension.
Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang IM. Bonderman D, et al. Circulation. 2007 Apr 24;115(16):2153-8. doi: 10.1161/CIRCULATIONAHA.106.661041. Epub 2007 Apr 9. Circulation. 2007. PMID: 17420352
Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
Gerges C, Gerges M, Friewald R, Fesler P, Dorfmüller P, Sharma S, Karlocai K, Skoro-Sajer N, Jakowitsch J, Moser B, Taghavi S, Klepetko W, Lang IM. Gerges C, et al. Among authors: skoro sajer n. Circulation. 2020 Feb 4;141(5):376-386. doi: 10.1161/CIRCULATIONAHA.119.041515. Epub 2020 Jan 3. Circulation. 2020. PMID: 31896275 Free article.
Risk factors for chronic thromboembolic pulmonary hypertension.
Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM. Bonderman D, et al. Eur Respir J. 2009 Feb;33(2):325-31. doi: 10.1183/09031936.00087608. Epub 2008 Sep 17. Eur Respir J. 2009. PMID: 18799507 Free article.
40 results